Clinical Trial: A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers

U.S., Aug. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07745907) titled 'A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers' on July 30.

Brief Summary: The trial is designed to evaluate the pharmacokinetics, safety, tolerability, and immunogenicity of AMG 691 in healthy Chinese and Japanese participants

Study Start Date: Aug. 07

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: AMG 691

AMG 691 will be administered subcutaneously

Recruitment Status: RECRUITING

Sponsor: Amgen

Published by HT Digital Content Services with permission from Health Daily Digest....